Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue

被引:18
作者
Das, S
Shraga, D
Gannon, C
Lam, TT
Feng, S
Brunet, LR
Telford, SR
Barthold, SW
Flavell, RA
Fikrig, E
机构
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,RHEUMATOL SECT,LAB CLIN INVEST 610,NEW HAVEN,CT 06520
[2] YALE UNIV,SCH MED,COMPARAT MED SECT,NEW HAVEN,CT 06520
[3] YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06520
[4] YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06520
[5] HARVARD UNIV,SCH PUBL HLTH,DEPT TROP PUBL HLTH,BOSTON,MA 02115
关键词
Lyme disease; Borrelia burgdorferi; p30; OppA homologue; outer surface protein;
D O I
10.1016/S0923-2508(97)85121-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A Borrelia burgdorferi chromosomal gene encodes a 30-kDa antigen (P30) that has considerable homology with periplasmic substrate-binding proteins of Gram-negative bacteria, and is recognized by antibodies in sera from a subset of patients with Lyme disease and from B. burgdorferi-infected mice. The p30 gene is 80f nucleotides in length and P30 contains 267 amino acids, with a predicted molecular mass of 30 kDa. The P30 amino acid region 36-258 has homology to conserved domains of the oligopeptide permease A of Gram-negative bacteria. Immunofluorescence studies using murine anti-P30 serum suggest that P30 is on the outer surface of B. burgdorferi. P30 expression could be detected in representatives of all 3 subspecies of B. burgdorferi sensu late, but not in all of the tested strains. Antibodies to P30 were detected in sera of 18 out of 82 patients (22%) with Lyme disease, including individuals with early- or late-stage infection. Although antibodies to P30 are present in the sera of C3H/HeN mice infected with B. burgdorferi for at least 90 days, immunization with recombinant P30 does not protect mice from infection. We conclude that P30 is a putative substrate-binding protein of B. burgdorferi and is immunologically recognized in human and murine Lyme borreliosis.
引用
收藏
页码:739 / 751
页数:13
相关论文
共 34 条
[1]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]   MOLECULAR ANALYSIS OF LINEAR PLASMID-ENCODED MAJOR SURFACE-PROTEINS, OSPA AND OSPB, OF THE LYME-DISEASE SPIROCHETE BORRELIA-BURGDORFERI [J].
BERGSTROM, S ;
BUNDOC, VG ;
BARBOUR, AG .
MOLECULAR MICROBIOLOGY, 1989, 3 (04) :479-486
[4]   IMMUNOGENIC INTEGRAL MEMBRANE-PROTEINS OF BORRELIA-BURGDORFERI ARE LIPOPROTEINS [J].
BRANDT, ME ;
RILEY, BS ;
RADOLF, JD ;
NORGARD, MV .
INFECTION AND IMMUNITY, 1990, 58 (04) :983-991
[5]   A 9.0-KILOBASE-PAIR CIRCULAR PLASMID OF BORRELIA-BURGDORFERI ENCODES AN EXPORTED PROTEIN - EVIDENCE FOR EXPRESSION ONLY DURING INFECTION [J].
CHAMPION, CI ;
BLANCO, DR ;
SKARE, JT ;
HAAKE, DA ;
GILADI, M ;
FOLEY, D ;
MILLER, JN ;
LOVETT, MA .
INFECTION AND IMMUNITY, 1994, 62 (07) :2653-2661
[6]   ANTIGENS OF BORRELIA-BURGDORFERI RECOGNIZED DURING LYME-DISEASE - APPEARANCE OF A NEW IMMUNOGLOBULIN-M RESPONSE AND EXPANSION OF THE IMMUNOGLOBULIN-G RESPONSE LATE IN THE ILLNESS [J].
CRAFT, JE ;
FISCHER, DK ;
SHIMAMOTO, GT ;
STEERE, AC .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (04) :934-939
[7]   MEGABASE-SIZED LINEAR DNA IN THE BACTERIUM BORRELIA-BURGDORFERI, THE LYME-DISEASE AGENT [J].
FERDOWS, MS ;
BARBOUR, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5969-5973
[8]   ROLES OF OSPA, OSPB, AND FLAGELLIN IN PROTECTIVE IMMUNITY TO LYME BORRELIOSIS IN LABORATORY MICE [J].
FIKRIG, E ;
BARTHOLD, SW ;
MARCANTONIO, N ;
DEPONTE, K ;
KANTOR, FS ;
FLAVELL, RA .
INFECTION AND IMMUNITY, 1992, 60 (02) :657-661
[9]   VACCINATION AGAINST LYME-DISEASE CAUSED BY DIVERSE BORRELIA-BURGDORFERI [J].
FIKRIG, E ;
TELFORD, SR ;
WALLICH, R ;
CHEN, MC ;
LOBET, Y ;
MATUSCHKA, FR ;
KIMSEY, RB ;
KANTOR, FS ;
BARTHOLD, SW ;
SPIELMAN, A ;
FLAVELL, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :215-221
[10]   SEROLOGIC DIAGNOSIS OF LYME-DISEASE USING RECOMBINANT OUTER SURFACE PROTEIN-A AND PROTEIN-B AND FLAGELLIN [J].
FIKRIG, E ;
HUGUENEL, ED ;
BERLAND, R ;
RAHN, DW ;
HARDIN, JA ;
FLAVELL, RA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1127-1132